TY - JOUR
T1 - Defining cross presentation for a wider audience
AU - Norbury, Christopher C.
N1 - Funding Information:
This work was supported by PHS grant AI097787 . We thank Nick Parekh, Gabriela Cosma and Dr. Laurence Eisenlohr for critical review of the manuscript, and Phillip Domeier for advice in design of the figures.
Publisher Copyright:
© 2016 Elsevier Ltd.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Cross presentation is the process of production of peptide-MHC Class I complexes by cells in which the antigen that is the source of peptide is not translated. The majority of recent studies have described many facets of the classical TAP-dependent cross presentation pathway, but numerous pathways for transfer of antigenic material from a donor to a recipient cell followed by subsequent MHC-I-restricted presentation have been established, including transfer of protein antigen, peptide, RNA, DNA or even peptide-MHC-I complexes. The extent to which each of these pathways generates overlapping or unique peptide repertoires is unknown, as is the contribution of each of these pathways to generation of protective CD8+ T cells during infection or anti-tumor immune responses.
AB - Cross presentation is the process of production of peptide-MHC Class I complexes by cells in which the antigen that is the source of peptide is not translated. The majority of recent studies have described many facets of the classical TAP-dependent cross presentation pathway, but numerous pathways for transfer of antigenic material from a donor to a recipient cell followed by subsequent MHC-I-restricted presentation have been established, including transfer of protein antigen, peptide, RNA, DNA or even peptide-MHC-I complexes. The extent to which each of these pathways generates overlapping or unique peptide repertoires is unknown, as is the contribution of each of these pathways to generation of protective CD8+ T cells during infection or anti-tumor immune responses.
UR - http://www.scopus.com/inward/record.url?scp=84963525466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963525466&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2016.04.003
DO - 10.1016/j.coi.2016.04.003
M3 - Review article
C2 - 27101579
AN - SCOPUS:84963525466
SN - 0952-7915
VL - 40
SP - 110
EP - 116
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
ER -